| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/18/2004 | WO2004022720A2 Methods for identifying antimicrobial compounds |
| 03/18/2004 | WO2004022719A2 Type 2 diabetes susceptibility genes |
| 03/18/2004 | WO2004022716A2 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 03/18/2004 | WO2004022709A2 Epitope sequences |
| 03/18/2004 | WO2004022708A2 Genes and proteins altering tau-related neurodegeneration |
| 03/18/2004 | WO2004022706A2 Immune cell receptor ligand and immune cell receptor |
| 03/18/2004 | WO2004022702A2 Methods and reagents for identifying inhibitors of viral protease activity. |
| 03/18/2004 | WO2004022701A2 Exponential amplification of nucleic acids using nicking agents |
| 03/18/2004 | WO2004022578A2 Methods, compositions and libraries pertaining pna dimer and pna oligomer synthesis |
| 03/18/2004 | WO2004022575A2 Bioinformatics analysis of cellular effects of artificial transcription factors |
| 03/18/2004 | WO2004022574A2 Improved methods for the synthesis of nucleic acids |
| 03/18/2004 | WO2004022091A1 Diacylglycerol production promoter |
| 03/18/2004 | WO2004022089A1 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 03/18/2004 | WO2004021986A2 Improved compositions and methods for cdna synthesis |
| 03/18/2004 | WO2004021978A2 Antisense modulation of endothelial specific molecule 1 expression |
| 03/18/2004 | WO2004021977A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 03/18/2004 | WO2004021871A2 Hcv assay |
| 03/18/2004 | WO2004021863A2 Methods for measuring rates of replication and death of nfectious microbial agents in an infected host organism |
| 03/18/2004 | WO2004021857A2 Method for retrospective birth dating of biomolecules, cells, tissues, organs and organisms |
| 03/18/2004 | WO2004011601A8 Corn event pv-zmir13 (mon863) plants and compositions and methods for detection thereof |
| 03/18/2004 | WO2004009845A3 Methods of screening for schizophrenia |
| 03/18/2004 | WO2004009842A3 Methods for identifying genes related to malfunctions of the central nervous system |
| 03/18/2004 | WO2004009760A3 Cytochrome p450 genetic variations |
| 03/18/2004 | WO2004007751A3 Nucleic acid labeling methods |
| 03/18/2004 | WO2004006952A3 Therapeutic tuberculosis vaccines |
| 03/18/2004 | WO2004003505A3 Methods for detecting and inactivating a prion |
| 03/18/2004 | WO2004001042A3 Microarrays displaying encoded molecules |
| 03/18/2004 | WO2003106706A3 Identification of specific marker genes and use thereof |
| 03/18/2004 | WO2003106653A3 Recombinant polynucleotides encoding pro-geldanamycin producing polyketide synthases and accessory proteins, and uses thereof |
| 03/18/2004 | WO2003102127A3 Human 5-ht7 receptor promoter sequence |
| 03/18/2004 | WO2003100557A3 Computer systems and methods for subdividing a complex disease into component diseases |
| 03/18/2004 | WO2003099210A3 Methods of modulating tubulin deacetylase activity |
| 03/18/2004 | WO2003093794A3 Methods for discovering tumor biomarkers and diagnosing tumors |
| 03/18/2004 | WO2003091388A3 Polymorphic olfactory receptor genes and arrays, kits and methods utilizing them |
| 03/18/2004 | WO2003089652A3 Comparative phenotype analysis of cells, including testing of biologically active compounds |
| 03/18/2004 | WO2003089594A3 A device and methods for concentrating prion protein isoforms |
| 03/18/2004 | WO2003084471A8 Compositions selective for adenosine diphosphate and methods of using same |
| 03/18/2004 | WO2003083142A3 UNIVERSAL DETECTION OF HUMAN PAPILLOMAVIRUS mRNA |
| 03/18/2004 | WO2003081257A3 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 1 (npff1) |
| 03/18/2004 | WO2003080825A3 Further bmp-2 inducible kinases and the uses thereof |
| 03/18/2004 | WO2003078660A3 Methods of identifying gene expression products resultant from alternative splicing and methods of diagnosing and treating disorders associated therewith |
| 03/18/2004 | WO2003078645A3 Methods for generating double stranded dna comprising a 3’ single stranded portion and uses of these complexes for recombination |
| 03/18/2004 | WO2003078583A3 Optimization of crossover points for directed evolution |
| 03/18/2004 | WO2003076950A3 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders |
| 03/18/2004 | WO2003072822A3 Mononucleotide repeats microsatellite markers for detecting microsatellite instability. |
| 03/18/2004 | WO2003072751A3 Expression system for human brain-specific voltage-gated sodium channel, type 1 |
| 03/18/2004 | WO2003070979A3 Materials and methods relating to cancer diagnosis |
| 03/18/2004 | WO2003070965A3 The eaat2 promoter and uses thereof |
| 03/18/2004 | WO2003069979A3 Plant preparations |
| 03/18/2004 | WO2003069310A3 Neurogenerative or neurotrophic factors for mitigating a symptom of ischemia |
| 03/18/2004 | WO2003068987A3 Discriminative analysis of clone signature |
| 03/18/2004 | WO2003067210A9 Methods and compositions for detecting the activation state of the multiple proteins in single cells |
| 03/18/2004 | WO2003066904A3 Methods for determining the response of cells to vegf and uses thereof |
| 03/18/2004 | WO2003065984A3 Methods and compositions for treating cardiovascular disease |
| 03/18/2004 | WO2003062463A3 One-step multiplex pcr for the identification and differentiation of campylobacter species |
| 03/18/2004 | WO2003062449A9 Methods of isolating specific cells of caenorhabditis elegans and obtaining genomic information therefrom |
| 03/18/2004 | WO2003057010A3 Droplet-based microfluidic oligonucleotide synthesis engine |
| 03/18/2004 | WO2003054523A3 Sensor and method for measuring the areal density of magnetic nanoparticles on a micro-array |
| 03/18/2004 | WO2003054509A3 Methods and devices for removal of organic molecules from biological mixtures using anion exchange |
| 03/18/2004 | WO2003054197A3 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 03/18/2004 | WO2003054166A3 Nucleotide polymorphisms associated with osteoarthritis |
| 03/18/2004 | WO2003050531A3 Method for displaying loops from immunoglobulin domains in different contexts |
| 03/18/2004 | WO2003048361A3 P55pik |
| 03/18/2004 | WO2003044172B1 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 03/18/2004 | WO2003042226A3 Single nucleotide polymorphisms in gh-1 |
| 03/18/2004 | WO2003041725A3 Regulation of cgmp-specific phosphodiesterase 9a |
| 03/18/2004 | WO2003038039A3 Novel cell-based assays for g-protein-coupled receptor-mediated activities |
| 03/18/2004 | WO2003037261A3 Methods and compositions for the treatment and diagnosis of pain disorders using 9805 |
| 03/18/2004 | WO2003036434A3 A system and method for consensus-calling with per-base quality values for sample assemblies |
| 03/18/2004 | WO2003035831A3 Lrrcaps as modifiers of the p53 pathway and methods of use |
| 03/18/2004 | WO2003032813A3 Methods for the treatment of carcinoma |
| 03/18/2004 | WO2003032809A3 Modulation of akt-dependent response to prevent restenosis |
| 03/18/2004 | WO2003025195A3 Nucleic acid constructs for the delivery of polynucleotides into dna-containing organelles,and uses thereof |
| 03/18/2004 | WO2003007800A8 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 03/18/2004 | WO2002103011A3 Selective gene amplification |
| 03/18/2004 | WO2002102972A3 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 03/18/2004 | WO2002095034A9 A retinoic acid metabolizing cytochrome p450 |
| 03/18/2004 | WO2002093166A8 Method for qualitative and/or quantitative determination of gender, species, race and/or geographical origin of biological materials |
| 03/18/2004 | WO2002090578A3 Methods and means of histone methylation |
| 03/18/2004 | WO2002090567A9 Sperm-specific cation channel, and uses therefor |
| 03/18/2004 | WO2002089498A3 Selection method |
| 03/18/2004 | WO2002076280A3 Methods and kits for determing a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a dna repair enzyme and a cancer |
| 03/18/2004 | WO2002064816A9 Multiple determinants for metabolic phenotypes |
| 03/18/2004 | US20040055039 Expression vector coding regulatory sequence for transcription of heterologous nucleotide sequences in fruit of plants; tissue engineering |
| 03/18/2004 | US20040055037 Plasmid comprising, internal ribosome entry sites and capable of amplification, expression and polycistronic cap independent translation; genetic engineering |
| 03/18/2004 | US20040055032 Pyrophosphatase stress-related proteins and methods of use in plants |
| 03/18/2004 | US20040055022 Compositions and methods for screening therapeutic agents |
| 03/18/2004 | US20040054267 Small volume in vitro analyte sensor |
| 03/18/2004 | US20040054190 Imaging prostate cancer |
| 03/18/2004 | US20040054165 Bacterial polysaccharide and biofilm development |
| 03/18/2004 | US20040054162 Comprises nucleoside/nucleotide/nucleic acid comprises substituted pyrimidine/purine derivatives; high speed; polymerases; blot analysis |
| 03/18/2004 | US20040054160 Nucleic-acid ink compositions for arraying onto a solid support |
| 03/18/2004 | US20040054156 Method and reagent for inhibiting hepatitis B viral replication |
| 03/18/2004 | US20040054149 Modified proteolytic enzyme for treatment of osteoarthritis |
| 03/18/2004 | US20040054135 Calcineurin polypeptide for diagnosis and treatment of cardiovascular disorders |
| 03/18/2004 | US20040054134 Hcv ns2/3 fragments and uses thereof |
| 03/18/2004 | US20040054133 Multiple sclerosis-related superantigen |
| 03/18/2004 | US20040053981 Such as 2-(5(6)-nitro-2-benzimidazoyl)-5-(4-nitrophenyl)furan; fluorescent quantitative analysis; for treatment/prevention of cancer |
| 03/18/2004 | US20040053941 Substituted pyrazine derivatives |
| 03/18/2004 | US20040053893 Comprises lysophospholipids attached to chromophore; enzyme inhibitors; drug screening; kits |